173 related articles for article (PubMed ID: 36076960)
1. Correlation between In Vitro Neutralization Assay and Serological Tests for Protective Antibodies Detection.
Bonifacio MA; Laterza R; Vinella A; Schirinzi A; Defilippis M; Di Serio F; Ostuni A; Fasanella A; Mariggiò MA
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076960
[TBL] [Abstract][Full Text] [Related]
2. Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays.
Valcourt EJ; Manguiat K; Robinson A; Lin YC; Abe KT; Mubareka S; Shigayeva A; Zhong Z; Girardin RC; DuPuis A; Payne A; McDonough K; Wang Z; Gasser R; Laumaea A; Benlarbi M; Richard J; Prévost J; Anand SP; Dimitrova K; Phillipson C; McGeer A; Gingras AC; Liang C; Petric M; Sekirov I; Morshed M; Finzi A; Drebot M; Wood H
Microbiol Spectr; 2021 Dec; 9(3):e0088621. PubMed ID: 34787495
[TBL] [Abstract][Full Text] [Related]
3. Multicentric evaluation of sensitivity of eight commercial anti-SARS-CoV-2 antibody assays and their correlation to virus neutralization titers in seropositive subjects.
Fajfr M; Pajer P; Ruzek D; Sleha R; Janovska S; Bohonek M; Kabickova H; Kubicková P; Stefanik M; Strakova P; Bostik P
Sci Rep; 2024 Jan; 14(1):1421. PubMed ID: 38228735
[TBL] [Abstract][Full Text] [Related]
4. Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
Lee B; Ko JH; Park J; Moon HW; Baek JY; Jung S; Lim HY; Kim KC; Huh K; Cho SY; Kang CI; Chung DR; Huh HJ; Chung CR; Kim YJ; Joo EJ; Kang ES; Peck KR
Front Cell Infect Microbiol; 2022; 12():822599. PubMed ID: 35493733
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference.
Graninger M; Jani CM; Reuberger E; Prüger K; Gaspar P; Springer DN; Borsodi C; Weidner L; Rabady S; Puchhammer-Stöckl E; Jungbauer C; Höltl E; Aberle JH; Stiasny K; Weseslindtner L
Microbiol Spectr; 2023 Feb; 11(1):e0231422. PubMed ID: 36622205
[TBL] [Abstract][Full Text] [Related]
6. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays.
Kohmer N; Westhaus S; Rühl C; Ciesek S; Rabenau HF
J Clin Virol; 2020 Aug; 129():104480. PubMed ID: 32505777
[TBL] [Abstract][Full Text] [Related]
7. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
[TBL] [Abstract][Full Text] [Related]
8. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891
[TBL] [Abstract][Full Text] [Related]
9. Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the
Pieri M; Infantino M; Manfredi M; Nuccetelli M; Grossi V; Lari B; Tomassetti F; Sarubbi S; Russo E; Amedei A; Benucci M; Casprini P; Stacchini L; Castilletti C; Bernardini S
Front Biosci (Landmark Ed); 2022 Feb; 27(2):74. PubMed ID: 35227017
[TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.
Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY
J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.
Montesinos I; Dahma H; Wolff F; Dauby N; Delaunoy S; Wuyts M; Detemmerman C; Duterme C; Vandenberg O; Martin C; Hallin M
J Clin Virol; 2021 Nov; 144():104988. PubMed ID: 34607239
[TBL] [Abstract][Full Text] [Related]
12. Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test.
Merluza J; Ung J; Makowski K; Robinson A; Manguiat K; Mueller N; Audet J; Chen JC; Strong JE; Wood H; Bello A
Microbiol Spectr; 2023 Feb; 11(1):e0378922. PubMed ID: 36602312
[TBL] [Abstract][Full Text] [Related]
13. Comparison of diagnostic performances of different serological tests for SARS-CoV-2 antibody detection in cats and dogs.
Ratti G; Lelli D; Moreno A; Stranieri A; Trogu T; Giordano A; Grassi A; Luzzago C; Decaro N; Paltrinieri S; Lauzi S
Transbound Emerg Dis; 2022 Nov; 69(6):3530-3539. PubMed ID: 36183165
[TBL] [Abstract][Full Text] [Related]
14. Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding Domain.
Lee B; Ko JH; Lee KH; Kim YC; Song YG; Park YS; Baek YJ; Ahn JY; Choi JY; Song KH; Kim ES; Bae S; Kim SH; Jeong HW; Kim SW; Kwon KT; Kim SH; Jeong H; Kim B; Kim SS; Choi WS; Peck KR; Kang ES
Microbiol Spectr; 2022 Dec; 10(6):e0266922. PubMed ID: 36250875
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
[TBL] [Abstract][Full Text] [Related]
16. A Single-Round Infection Fluorescent SARS-CoV-2 Neutralization Test for COVID-19 Serological Testing at a Biosafety Level-2 Laboratory.
Zou J; Xia H; Shi PY; Xie X; Ren P
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746682
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies.
Zedan HT; Yassine HM; Al-Sadeq DW; Liu N; Qotba H; Nicolai E; Pieri M; Bernardini S; Abu-Raddad LJ; Nasrallah GK
Sci Rep; 2022 Nov; 12(1):19020. PubMed ID: 36347859
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Valcourt EJ; Manguiat K; Robinson A; Chen JC; Dimitrova K; Philipson C; Lamoureux L; McLachlan E; Schiffman Z; Drebot MA; Wood H
Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115294. PubMed ID: 33387896
[TBL] [Abstract][Full Text] [Related]
19. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.
Patel EU; Bloch EM; Clarke W; Hsieh YH; Boon D; Eby Y; Fernandez RE; Baker OR; Keruly M; Kirby CS; Klock E; Littlefield K; Miller J; Schmidt HA; Sullivan P; Piwowar-Manning E; Shrestha R; Redd AD; Rothman RE; Sullivan D; Shoham S; Casadevall A; Quinn TC; Pekosz A; Tobian AAR; Laeyendecker O
J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139419
[TBL] [Abstract][Full Text] [Related]
20. Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays.
Weidner L; Gänsdorfer S; Unterweger S; Weseslindtner L; Drexler C; Farcet M; Witt V; Schistal E; Schlenke P; Kreil TR; Jungbauer C
J Clin Virol; 2020 Aug; 129():104540. PubMed ID: 32652475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
